sativex oromucosal spray
gw pharma (international) b.v. - delta-9-tetrahydrocannabinol botanical drug substance (thc bds); cannabidiol botanical drug substance (cbd bds) - oromucosal spray, solution - 27 mg/ml + 25 milligram(s)/millilitre - other analgesics and antipyretics; cannabinoids
sativex oromucosal spray
jazz pharmaceuticals ireland limited - delta-9-tetrahydrocannabinol botanical drug substance (thc bds); cannabidiol botanical drug substance (cbd bds) - oromucosal spray, solution - other analgesics and antipyretics; cannabinoids
nanocdb- none solution/ drops
creative essences inc - cannabidiol (unii: 19gbj60sn5) (cannabidiol - unii:19gbj60sn5) - as prescribed by health professionals.
epidiolex 100mg/ml oral solution
gw pharma ltd - cannabidiol - oral solution - 100mg/1ml
epidiolex 25mg/ml oral solution
gw pharma ltd - cannabidiol - oral solution - 25mg/1ml
rapamune tablet 2 mg
pfizer private limited - (active filler coat) sirolimus @ 100% - tablet, sugar coated - 2.0 mg - (active filler coat) sirolimus @ 100% 2.0 mg
rapamune oral solution 1 mgml
pfizer private limited - sirolimus - solution - 1 mg/ml - sirolimus 1 mg/ml
rapamune tablet 1 mg
pfizer private limited - (active filler coat) sirolimus @ 100% - tablet, sugar coated - 1.00 mg - (active filler coat) sirolimus @ 100% 1.00 mg
rapamune tablet 0.5 mg
pfizer private limited - (active filler coat) sirolimus - tablet, sugar coated - (active filler coat) sirolimus 0.5 mg
gd cann-c
gd pharma pty ltd - cannabidiol -